118 related articles for article (PubMed ID: 7671094)
1. Clinical uses of insulin-like growth factor I.
Hussain MA; Froesch ER
Adv Endocrinol Metab; 1995; 6():143-65. PubMed ID: 7671094
[No Abstract] [Full Text] [Related]
2. Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
Froesch ER; Hussain MA; Schmid C; Zapf J
Diabetes Metab Rev; 1996 Oct; 12(3):195-215. PubMed ID: 8959385
[No Abstract] [Full Text] [Related]
3. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
4. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
Ranke MB; Wollmann HA; Savage MO
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
[No Abstract] [Full Text] [Related]
5. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
Clemmons DR
Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
[TBL] [Abstract][Full Text] [Related]
6. [Human insulin-like growth factor I and treatment in diabetes].
Koivisto VA
Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
[No Abstract] [Full Text] [Related]
7. [Diabetes mellitus and sports. Why the athletic diabetic patient uses less insulin].
Neye H
Med Monatsschr Pharm; 1994 Sep; 17(9):273-6. PubMed ID: 7968779
[No Abstract] [Full Text] [Related]
8. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
Dunger DB; Acerini CL
Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
[TBL] [Abstract][Full Text] [Related]
9. Clinical uses of insulin-like growth factor I.
Bondy CA; Underwood LE; Clemmons DR; Guler HP; Bach MA; Skarulis M
Ann Intern Med; 1994 Apr; 120(7):593-601. PubMed ID: 8116999
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitizers.
Das S
J Assoc Physicians India; 1997; Suppl 1():32-6. PubMed ID: 11235632
[No Abstract] [Full Text] [Related]
11. Clinical significance of insulin resistance.
Bell PM
Diabet Med; 1996 Jun; 13(6):504-9. PubMed ID: 8799651
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance: the clinical spectrum.
Mantzoros CS; Flier JS
Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
[No Abstract] [Full Text] [Related]
13. Treatment with insulin glargine does not suppress serum IGF-1.
Slawik M; Schories M; Busse Grawitz A; Reincke M; Petersen KG
Diabet Med; 2006 Jul; 23(7):814-7. PubMed ID: 16842489
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I and altered renal hemodynamics in growth hormone deficiency, acromegaly, and type I diabetes mellitus.
Hoogenberg K; ter Wee PM; Lieverse AG; Sluiter WJ; Dullaart RP
Transplant Proc; 1994 Apr; 26(2):505-7. PubMed ID: 8171527
[No Abstract] [Full Text] [Related]
15. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
Rosenbloom AL
J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
[No Abstract] [Full Text] [Related]
16. Insulin-like growth factor I and the kidney.
O'Shea M; Miller SB; Hammerman MR
Semin Nephrol; 1993 Jan; 13(1):96-108. PubMed ID: 8434191
[No Abstract] [Full Text] [Related]
17. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
18. How recombinant insulin analogs improve insulin therapy of diabetes mellitus: pathophysiology, clinical practice and recommendations.
TatoĊ J; Milicevic Z; Mozejko-Pastewka B; Bernas M; Czech A
Med Sci Monit; 2001; 7(4):848-59. PubMed ID: 11433220
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I (lGF-l): safety and efficacy.
Laron Z
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():78-85. PubMed ID: 16456486
[TBL] [Abstract][Full Text] [Related]
20. Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin.
Cotrozzi G; Giusti S; Bini S; Carloni V; Mazzocca A; Frati M
J Endocrinol Invest; 1999; 22(10 Suppl):88-9. PubMed ID: 10727064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
